Although increased expression of APE1/Ref-1 by nucleus or cytoplasmic staining has been reported in patients with prostate cancer [24,25], no studies have been published regarding changes in plasma APE1/Ref1 level in patients with prostate cancer. Here, APEX1 is linked to prostate cancer.